On the whole, however, PDPRA’s impact on the pharmaceutical industry is not nearly as potentially significant and punitive in terms of price controls as H.R. 3 would be if it became law.
On the whole, however, PDPRA’s impact on the pharmaceutical industry is not nearly as potentially significant and punitive in terms of price controls as H.R. 3 would be if it became law.